18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.

OBJECTIVE: The most widely studied positron emission tomography ligand for in vivo beta-amyloid imaging is (11)C-Pittsburgh compound B ((11)C-PIB). Its availability, however, is limited by the need for an on-site cyclotron. Validation of the (18)F-labeled PIB derivative (18)F-flutemetamol could sig...

書誌詳細
主要な著者:	Vandenberghe, R, Van Laere, K, Ivanoiu, A, Salmon, E, Bastin, C, Triau, E, Hasselbalch, S, Law, I, Andersen, A, Korner, A, Minthon, L, Garraux, G, Nelissen, N, Bormans, G, Buckley, C, Owenius, R, Thurfjell, L, Farrar, G, Brooks, D
フォーマット:	Journal article
言語:	English
出版事項:	2010

類似資料

Binary classification of ¹⁸F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI.
著者:: Vandenberghe, R, 等
出版事項: (2013)

Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease.
著者:: Nelissen, N, 等
出版事項: (2009)

Longitudinal changes in 18F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations
著者:: Emma S. Luckett, 等
出版事項: (2023-01-01)

Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment
著者:: Hugh G. Pemberton, 等
出版事項: (2023-05-01)

Abeta amyloid deposition in the language system and how the brain responds.
著者:: Nelissen, N, 等
出版事項: (2007)

Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods
著者:: Mark R. Battle, 等
出版事項: (2018-12-01)

Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET
著者:: Yong-Jin Park, 等
出版事項: (2025-01-01)

Amyloid-Targeting PET Tracer [18F]Flutemetamol Accumulates in Atherosclerotic Plaques
著者:: Sanna Hellberg, 等
出版事項: (2019-03-01)

Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET
著者:: Si Eun Kim, 等
出版事項: (2020-01-01)

Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population
著者:: Lyduine E. Collij, 等
出版事項: (2023-11-01)

Plasma protein biomarkers for the prediction of CSF amyloid and tau and [18F]-flutemetamol PET scan result
著者:: Westwood, S, 等
出版事項: (2018)

Author Correction: Concordance in detecting amyloid positivity between 18F-florbetaben and 18F-flutemetamol amyloid PET using quantitative and qualitative assessments
著者:: Soo Hyun Cho, 等
出版事項: (2021-03-01)

Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging.
著者:: Koole, M, 等
出版事項: (2009)

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result
著者:: Sarah Westwood, 等
出版事項: (2018-12-01)

In vivo amyloid imaging in cortical superficial siderosis.
著者:: Dhollander, I, 等
出版事項: (2011)

Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques
著者:: Milos D. Ikonomovic, 等
出版事項: (2018-06-01)

Longitudinal Assessment of Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer’s Disease
著者:: Shizuo Hatashita, 等
出版事項: (2019-09-01)

Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer’s disease with PET imaging agents 18F-flutemetamol and 18F-florbetaben
著者:: Hye Joo Son, 等
出版事項: (2018-07-01)

Functional Changes in the Language Network in Response to Increased Amyloid β Deposition in Cognitively Intact Older Adults.
著者:: Adamczuk, K, 等
出版事項: (2014)

Anatomical based reconstruction of dynamic brain PET images using N-[11C]-methylpiperidin-4-YL-proprionate ([11C]-PMP) in elderly normals
著者:: Nelissen, N, 等
出版事項: (2007)

Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies
著者:: Fiona Heeman, 等
出版事項: (2019-03-01)

Early-phase 18F-FP-CIT and 18F-flutemetamol PET were significantly correlated
著者:: Young-Sil An, 等
出版事項: (2021-06-01)

Temporal and anatomical distribution of 18F-flutemetamol uptake in canine brain using positron emission tomography
著者:: Taesik Yun, 等
出版事項: (2020-01-01)

Comparison of [18F]Flutemetamol and [11C]Pittsburgh Compound-B in cognitively normal young, cognitively normal elderly, and Alzheimer's disease dementia individuals
著者:: Val J. Lowe, 等
出版事項: (2017-01-01)

Automatic lesion detection and segmentation in 18F-flutemetamol positron emission tomography images using deep learning
著者:: Chan Ju Ryu
出版事項: (2022-12-01)

A European multicentre PET study of fibrillar amyloid in Alzheimer's disease.
著者:: Nordberg, A, 等
出版事項: (2013)

Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects
著者:: James M. Mountz, 等
出版事項: (2015-01-01)

18F-flutemetamol PET/CT imaging in the diagnosis of mild cognitive impairment and Alzheimer's disease：a preliminary study
著者:: LEI Zhe, 等
出版事項: (2022-07-01)

Quantitative Evaluation of 18F-Flutemetamol PET in Patients With Cognitive Impairment and Suspected Alzheimer's Disease: A Multicenter Study
著者:: Hiroshi Matsuda, 等
出版事項: (2021-01-01)

Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers.
著者:: Adamczuk, K, 等
出版事項: (2013)

Computed Tomography Density and β-Amyloid Deposition of Intraorbital Optic Nerve May Assist in Diagnosing Mild Cognitive Impairment and Alzheimer’s Disease: A 18F-Flutemetamol Positron Emission Tomography/Computed Tomography Study
著者:: Han Wu, 等
出版事項: (2022-03-01)

Cholinergic depletion and basal forebrain volume in primary progressive aphasia
著者:: Jolien Schaeverbeke, 等
出版事項: (2017-01-01)

Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
著者:: Dietmar Rudolf Thal, 等
出版事項: (2019-11-01)

Correction to: Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
著者:: Dietmar Rudolf Thal, 等
出版事項: (2020-08-01)

Drug development in Alzheimer’s disease: the contribution of PET and SPECT
著者:: Lieven Denis Herwig Declercq, 等
出版事項: (2016-03-01)

Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults
著者:: Emma S. Luckett, 等
出版事項: (2023-07-01)

Image reconstruction methods affect software-aided assessment of pathologies of [18F]flutemetamol and [18F]FDG brain-PET examinations in patients with neurodegenerative diseases
著者:: Elin Lindström, 等
出版事項: (2020-01-01)

Association of Alzheimer’s disease polygenic risk scores with amyloid accumulation in cognitively intact older adults
著者:: Emma S. Luckett, 等
出版事項: (2022-09-01)

Levels of islet amyloid polypeptide in cerebrospinal fluid and plasma from patients with Alzheimer's disease.
著者:: Nina Schultz, 等
出版事項: (2019-01-01)

3D shape perception in posterior cortical atrophy: a visual neuroscience perspective
著者:: Gillebert, C, 等
出版事項: (2015)